DNA Shariah Compliance
Screening Methodology: AAOIFI
UNLOCK FOR FREE
Last Updated: March 11, 2026
Report Source: 2025 Annual Report
Ginkgo Bioworks Holdings Inc. Stock Analysis DNA
United States Health Care Small Cap Report: Ginkgo Bioworks Holdings, Inc. is a biotech company. The company is headquartered in Boston, Massachusetts and currently employs 834 full-time employees. The company went IPO on 2021-04-19. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatics support services, offered to both government and non-government customers through its two core offerings: Canopy and Horizon. The firm provides comprehensive research and development services spanning the genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics.
Read More Ginkgo Bioworks Holdings Inc (DNA) Chart
Key Statistics of Ginkgo Bioworks Holdings Inc (DNA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$6.42Volume
1.63MP/E Ratio (TTM)
-52 Week Range
Market Cap
543.49MAvg. Volume
1.30MDividend Yield
-Financial Metrics & Statements of Ginkgo Bioworks Holdings Inc (DNA)
Super Investors Invested in Ginkgo Bioworks Holdings Inc (DNA)
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Cathie Wood
% Portfolio:
0 Recent Activity:-100.00%
Joel Greenblatt
% Portfolio:
0 Recent Activity:-100.00%
Jefferies Group
% Portfolio:
0 Recent Activity:-100.00%
FAQ's for Ginkgo Bioworks Holdings Inc (DNA)
- According to Musaffa’s Shariah screening methodology, Ginkgo Bioworks Holdings Inc (DNA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
Alternate Halal Stocks for Ginkgo Bioworks Holdings Inc (DNA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
